South Korea’s proportion of hard-core vegetarians has turned out to be a minimal 7.6 percent, with 92.4 percent being non-vegetarians, according to a survey by the Korea Agro-Fisheries & Food Trade Corp. on 5,510 adult respondents.
The survey was delegated by local pollster Global Research based on seven levels of vegetarian practice.
The ‘flexitarians,' or vegetarians who eat meat on occasion, made up 79.7 percent of the population or 333 persons.
The ‘pollos' who eat milk, eggs, fish, and chicken but not beef or pork made up 11% of the population, whereas the 'pescos,' who only consume seafood, comprised 6.2 percent.
In total, flexitarians, pollos, and pescanos accounted for 96.9 percent of the population.
Only 3.1 percent of vegetarians ate no meat of any kind. That's 0.2 percent of all respondents in the poll.
Only 0.7 percent of the group were classified as ‘lacto-ovos,' those who eat only eggs and milk, while 1.4 percent comprised the ‘ovos,' or egg eaters, who do not consume milk.
Of the respondents, 0.5 percent were made up of persons labeled with the term ‘lactos,' who eat fruits, vegetables, and milk, and another 0.5 percent were vegans,' who only consume vegetables and fruits.


Gold Prices Slip as Strong Dollar and High Treasury Yields Weigh
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds
Wall Street Rises as Oil Prices Ease, Nasdaq Hits Record
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
Oil Prices Fall as Middle East Exports Recover, G7 Eases Supply Fears
Samsung, SK Hynix Shares Fall Ahead of Q3 Earnings
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Crypto Market Selloff Wipes Out $100B as Bitcoin Falls Below $83K
Asian Currencies Steady as Dollar Holds Near 18-Month High
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak
FDA Weighs Safety Standards for Psychedelic Therapies
U.S. Issues Cuba Health Alert as Illnesses Rise
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
Thailand Plans Dual-Class Shares to Revive IPO Market 



